BIBLIOGRAPHY
This new section of the site is dedicated to articles related to fenfluramine, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat.
We have previously shown that neonatal administration of (+/-)3,4-methylenedioxymethamphetamine and (+)fenfluramine produce deficits in spatial and path integration learning, whereas (+)methamphetamine causes deficits in spatial...
Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys.
Previous research with psychostimulants has suggested a negative relationship between both potency and efficacy as a reinforcer and serotonergic potency, particularly relative to dopaminergic potency.
MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation.
Chronic L-3,4-dihydroxyphenylalanine (L-DOPA) pharmacotherapy in Parkinson's disease is often accompanied by the development of abnormal and excessive movements known as dyskinesia.
Effects of chronic fenfluramine administration on hypothalamic neuropeptide mRNA expression.
Appetite suppressants lose efficacy when given chronically; the mechanisms are unknown.
The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
Biochemical, genetic and imaging studies support the involvement of the serotonin (5-HT) system in anorexia nervosa.